Ex Parte YAMAGUCHI et al - Page 6



          Appeal No. 2001-1596                                                        
          Application 09/296,102                                                      

          § 1.109, provided in its last two sentences (emphasis added):               
               The applicant or patent owner may file a statement                     
               commenting on the reasons for allowance within such time as            
               may be specified by the examiner.  Failure to file such a              
               statement shall not give rise to any implication that the              
               applicant or patent owner agrees with or acquiesces in the             
               reasoning of the examiner.                                             
          Effective Dec. 1, 1997, § 1.109 was removed and its substance               
          incorporated into § 1.104 as § 1.104(e)(1203 O.G. 63, 79 (Oct.              
          21, 1997)).  Subsequently, effective Nov. 7, 2000, § 1.104(e) was           
          amended by deleting its last sentence (underlined above), the               
          accompanying discussion stating that this statement in the rule             
          was “obsolete and out of step with recent case law” and citing as           
          examples of such case law four decisions of the United States               
          Supreme Court and Court of Appeals for the Federal Circuit2 (1238           
          O.G. 77, 103 (Sep. 19, 2000)).                                              
               Appellants argue that, in not filing a statement or comments           
          in response to the examiner’s reasons for allowance, they were              
          entitled to rely on the above-noted provision of the last                   
          sentence of 37 CFR § 1.109/1.104(e), i.e., that failure to file             

               2 Warner-Jenkinson Co. v. Hilton Davis Chem. Co., 520 U.S.             
          17, 41 USPQ2d 1865 (1997); Markman v. Westview Instruments, 52              
          F.3d 967, 34 USPQ2d 1321 (Fed. Cir. 1995), aff’d, 517 U.S. 320,             
          38 USPQ2d 1461 (1996); Vitronics Corp. v. Conceptronic Inc., 90             
          F.3d 1576, 39 USPQ2d 1573 (Fed. Cir. 1996); Zenith Labs., Inc. v.           
          Bristol-Myers Squibb Co., 19 F.3d 1418, 30 USPQ2d 1285 (Fed. Cir.           
          1996).                                                                      
                                          6                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007